IXICO (LON:IXI) Shares Down 9.9% – What’s Next?

IXICO plc (LON:IXI)’s share price was down 9.9% during trading on Friday . The company traded as low as GBX 8 and last traded at GBX 8. Approximately 242,177 shares were traded during trading, an increase of 114% from the average daily volume of 113,365 shares. The stock had previously closed at GBX 8.88.

IXICO Stock Performance

The firm has a market cap of £7.18 million, a PE ratio of -4.19, a PEG ratio of -0.38 and a beta of 0.86. The company has a 50-day simple moving average of GBX 10.89 and a two-hundred day simple moving average of GBX 11.46. The company has a quick ratio of 4.90, a current ratio of 2.85 and a debt-to-equity ratio of 3.32.

IXICO (LON:IXI) last posted its earnings results on Tuesday, December 9th. The company reported GBX (1.85) earnings per share (EPS) for the quarter. IXICO had a negative net margin of 31.10% and a negative return on equity of 19.14%. As a group, equities research analysts forecast that IXICO plc will post -289.3584879 earnings per share for the current year.

About IXICO

IXICO is a global leader in neuroscience imaging and biomarker analytics, using its proprietary AI-driven platform to help advance the treatment of neurological disorders and reduce the uncertainties associated with drug discovery, development and monitoring.

By unlocking valuable insights into drug safety and efficacy, IXICO has built a global reputation and 20-year track record as an end-to-end Imaging Contract Research Organisation (iCRO) managing and analysing neurological clinical trials.